Buys
Open market- Shares
- +58,060
- Avg price
- $0.8483
- Total value
- +$49,252
Chad Cowan - Chief Scientific Officer at Century Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Scientific Officer
- Issuer ticker
- IPSC on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Chad Cowan in Century Therapeutics, Inc.
Sells
Open market- Shares
- -5,462
- Avg price
- $0.5010
- Total value
- -$2,736
Net
Past year- Shares
- +52,598
- Share %
- 83%
- Total value
- +$46,516
Reported holdings for Chad Cowan in Century Therapeutics, Inc.
Form 4 holding
Chief Scientific Officer
Century Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 1,175,322
- Estimated value
- $2,656,227
- Report date
- 11 Jun 2026
- Price
- $2.26
- Ownership
- Direct
Form 4 holding
Chief Scientific Officer
Century Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 10,697
- Estimated value
- $24,175
- Report date
- 11 Jun 2026
- Price
- $2.26
- Ownership
- By Trust
Form 4 holding
Chief Scientific Officer
Century Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 265,000
- Estimated value
- Report date
- 02 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Chad Cowan in Century Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.